Pediatrics Doctors in Fallon, NV Accepting Medicare

3 Pediatrics doctors found. Showing 1 - 3

Dr. Lana Lugue Narag, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1077 New River Parkway, Fallon, NV 89406 Phone: 775-428-2747    Fax: 775-428-2179

Dr. Luann D Ochsner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 801 E Williams Ave # 2208, Fallon, NV 89406 Phone: 775-867-7740    Fax: 775-867-3611

Pacita Platon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1001 Rio Vista Dr, Fallon Tribal Health Center, Fallon, NV 89406 Phone: 775-423-3634    Fax: 775-423-5694

News Archive

Weight loss does not reduce heart disease risks among Type 2 diabetes patients: Study

A landmark study investigating the long-term effects of weight loss on the risks of cardiovascular disease among patients with Type 2 diabetes has now concluded, with significant results to be published today in the New England Journal of Medicine.

WSU researchers working on new system to reduce negative effects of cancer drugs

Wichita State University researchers are working on a new system that could decrease the negative effects of cancer drugs on patients.

FDA issues emergency use authorization for peramivir anti-viral drug

BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

Scientists discover serum biochemical signature that predicts Alzheimer's

Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

Read more Medical News

› Verified 1 days ago